As healthcare professionals, it is crucial to understand the complexities of Parkinson's Disease (PD), a neurodegenerative disorder that has far-reaching implications on the quality of life of patients.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to a dopamine deficit in the striatum. While the exact cause remains unknown, both genetic and environmental factors are believed to play a role.
PD presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. Non-motor symptoms, including cognitive impairment, mood disorders, and autonomic dysfunction, may precede motor symptoms and significantly impact a patient's life.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging techniques can provide supportive evidence but are not diagnostic.
Management of PD is symptomatic, focusing on improving quality of life. Pharmacological treatment principally involves dopamine replacement or mimicking its effects. Non-pharmacological interventions include physical therapy and deep brain stimulation.
PD is a progressive disease with no cure. However, advancements in research are promising, with ongoing studies exploring neuroprotective strategies and disease-modifying therapies.
Understanding PD's complexity is key to providing comprehensive care to patients. As healthcare professionals, we must stay updated on the latest research developments to improve patient outcomes. Continued focus on patient-centered care, encompassing not just the motor symptoms but also the non-motor manifestations of PD, will ensure a holistic approach to management.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation